Latest News & Upcoming Events
Everything We Know About AMD and Dark Adaptation
A roundtable discussion between leading optometrists led by Dr. Greg Caldwell summarizing current understanding of early stages of AMD, the link to impaired dark adaptation and the benefits of implementing dark adaptation testing into optometric practice.
How to Treat Early AMD
Dr. Julie Rodman explains that from a pathophysiological standpoint AMD is AMD—regardless of stage or how long the disease has progressed. In this article, she lists the treatments that should be offered to patients— even at the earliest stages of AMD.
The Clinical Significance of Rod Intercept in the Management of AMD
Dr. Timothy Earley provides his insights
Why Structure and Function Together are Necessary
Dr. Karpecki and Dr. Lowe evaluate both the structure and function of the retina to help diagnose AMD and monitor disease progression.
How to Make AMD Excellence the Norm in Your Practice
Here’s a snapshot of how fellow eye care colleagues added new AMD protocols in their practices to make implementation easier from day one.
Dark Adaptation: Now a Cornerstone of Optometric Education
Here’s what faculty from three top schools have to say about dark adaptation in their programs today.
This is Standard of Care in My Practice
Dr. Gary Kirman, one of the earliest adopters of dark adaptation testing in optometric practice, reflects on his role in helping to create an elevated standard of care for practices everywhere.
I Take Comfort in Greater Certainty
Dr. Glenn Corbin, one of the earliest adopters of dark adaptation testing in optometric practice, explains how using both structural and functional testing removes the guesswork out of AMD diagnosis and monitoring.
What a Long, Strange Trip It’s Been…
Dr. Greg Jackson takes a moment to reminisce about the shift that occurred between 1998 and 2021 that brought dark adaptation testing into mainstream optometry.
5 Tips for Recommending Smoking Cessation Programs
Dr. Timothy Earley shares tips on how to talk to patients about smoking cessation, the biggest modifiable risk factor for AMD, and how to motivate them to quit.
